Literature DB >> 8537094

Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells.

L Iakoubov1, O Rokhlin, V Torchilin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8537094     DOI： 10.1016/0165-2478(95)00066-e

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


× No keyword cloud information.
  15 in total

1.  Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro.

Authors:  Aruna Roby; Suna Erdogan; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2005-12-02       Impact factor: 5.571

2.  Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.

Authors:  Federico Perche; Niravkumar R Patel; Vladimir P Torchilin
Journal:  J Control Release       Date:  2012-09-10       Impact factor: 9.776

3.  Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

4.  Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.

Authors:  Swati Biswas; Namita S Dodwadkar; Rupa R Sawant; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2011-09-12       Impact factor: 4.774

5.  Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.

Authors:  Radhika Narayanaswamy; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2021-03-02       Impact factor: 4.200

6.  NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.

Authors:  John N Barry; Alexey A Vertegel
Journal:  Nano Life       Date:  2013-12-27

7.  Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

8.  Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.

Authors:  Tamer A ElBayoumi; Vladimir P Torchilin
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

9.  Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Eur J Pharm Sci       Date:  2007-06-07       Impact factor: 4.384

10.  On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles.

Authors:  Xiaoyang Ren; Rupa R Sawant; Ekaterina Y Lukianova-Hleb; Xiangwei Wu; Vladimir P Torchilin; Dmitri O Lapotko
Journal:  Nat Med       Date:  2014-06-01       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.